Sandrine Valsesia‐Wittmann

Author

Also Known As

S Valsesia-Wittmann, S. Valsesia-Wittmann, Sandrine Valsesia-Wittmann, Sandrine Valsesia‐Wittmann, Valsesia-Wittmann Sandrine, Valsesia-Wittmann, S.

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Inserm Centre Léon Bérard Université Claude Bernard Lyon 1 Centre de Recherche en Cancérologie de Lyon Centre National de la Recherche Scientifique

About

Sandrine Valsesia‐Wittmann is an author at Inserm specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.7K
2	Cell Biology	8	8	1.4K
3	Immunology	8	8	529
4	Natural Sciences	1	1	81
5	Biomolecular Engineering	1	1	81

Sandrine Valsesia‐Wittmann

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Induction of EMT by Twist Proteins as a Collateral Effect of Tumor-Promoting Inactivation of Premature Senescence Stéphane Ansieau, Jérémy Bastid, Agnès Doreau, Cancer Cell MedicineCancer GrowthEpithelial-mesenchymal InteractionsCellular SenescenceCell Biology	2008	686
Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells Sandrine Valsesia‐Wittmann, Maud Magdeleine, Sébastien Dupasquier, Cancer Cell Tumor BiologyOncogenic AgentMedicineOncogenic CooperationCancer Genomics	2004	259
Mutant p53R175H upregulates Twist1 expression and promotes epithelial–mesenchymal transition in immortalized prostate cells Ira Kogan-Sakin, Yuval Tabach, Y Buganim, Cell Death and Differentiation Tumor BiologyTranscriptional RegulationImmortalized Prostate CellsMedicineCancer Cell Biology	2010	149
Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients Michaëla Semeraro, Sylvie Rusakiewicz, Véronique Minard-Colin, Science Translational Medicine	2015	141
Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors Sandrine Valsesia‐Wittmann, Antoine Drynda, Gilbert Deléage, Journal of Virology Virus StructureHost RangeViral ReplicationMolecular VirologySynthetic Virology	1994	115
Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity Minh Ngoc Duong, Aurore Cleret, Eva‐Laure Matera, Breast Cancer Research	2015	102
<i>In Vitro</i>and<i>In Vivo</i>Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:msup><mml:mrow><mml:mtext>CD</mml:mtext><mml:mn mathvariant="bold">33</mml:mn></mml:mrow><mml:mrow><mml:mo mathvariant="bold">+</mml:mo></mml:mrow></mml:msup></mml:math>Acute Myeloid Leukemia Aurélie Dutour, Virna Marin, Irene Pizzitola, Advances in Hematology Mn Mathvariant=T-regulatory CellImmunologyImmunotherapyMo Mathvariant=	2012	99
Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU Sandrine Valsesia‐Wittmann, Frances J. Morling, Bo Nilson, Journal of Virology Viral ReplicationSuch Chimeric EnvelopesSynthetic VirologyImmunologyTransduction Efficiency	1996	81
BTG2TIS21/PC3 induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells Fatiha el-Ghissassi, Sandrine Valsesia‐Wittmann, Nicole Falette, Oncogene Pc12 CellsCell RegulationApoptosisImmunologyCell Death	2002	71
Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade Tala Shekarian, Éva Sivadó, Anne-Catherine Jallas, Science Translational Medicine Uv-inactivated RotavirusImmunologyImmunoeditingPathologyImmune Cell Therapy	2019	70

Page 1